Early Treatment With Intravenous Immunoglobulins and Outcomes of Patients With Anti-IgLON5 Disease
Thomas Grüter(Klinikum Lippe), Christian G. Bien(Bielefeld University), Sonka Benesch(Antea Group (France)), Sebastian Baatz(Antea Group (France)), Francesc Graus(Boston University), Luise Appeltshauser(Antea Group (France)), Agnita J.W. Boon(Haga Hospital), Sarah Bernsen(Antea Group (France)), Achim Berthele, Birgit Berger(Antea Group (France)), Frank Leypoldt, Lídia Sabater(Fundació Clínic per a la Recerca Biomèdica), Annette Baumgärtner(Antea Group (France)), María Elena Erro(Complejo Hospitalario de Navarra), Anna Heidbreder(Innsbruck Medical University), Yvette S. Crijnen, Anja Tietz(Christian-Albrechts-Universität zu Kiel), Franziska Thaler(Goethe University Frankfurt), Oliver Bähr(Frankfurt Cancer Institute), Gian Maria Asioli(Antea Group (France)), Maarten J. Titulaer(Erasmus MC), Sascha Berning(Antea Group (France)), Andre Dik(University of Münster), Juna M. de Vries, Josep Dalmau(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Ralf Gold(St. Josef-Hospital), Robert L. Berger(Antea Group (France)), Carolin Baade‐Büttner(Antea Group (France)), Stjepana Kovac(University of Münster), Martin Berghoff(University of Giessen), Justina Dargvainiene(University Hospital Schleswig-Holstein), Romana Höftberger(The Ohio State University Wexner Medical Center), Bettina Balint(Heidelberg University), Sebastian Bauer(Antea Group (France)), Andreas van Baalen(University Hospital Schleswig-Holstein), Michael Adelmann(Antea Group (France)), Tobias Baumgartner(University of Bonn), Jonathan Wickel(Jena University Hospital), Antonios Bayas(University of Augsburg), Ilya Ayzenberg(St. Josef-Hospital), Robin W. van Steenhoven(Erasmus MC), Frank Seifert(Universitätsklinikum Erlangen), Carles Gaig(Hospital Clínic de Barcelona), Stefanie Becker(Antea Group (France)), Andrea Kraft(Martha-Maria Hospital), Klaus-Peter Wandinger(University Hospital Schleswig-Holstein), Jan Lewerenz(Universität Ulm), Gregor Kuhlenbäumer(University Hospital Schleswig-Holstein), Lucie de Azevedo(Katholisches Klinikum Koblenz)
Cited by 7
Related Papers
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
|The Lancet Neurology|2008|3.5k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
Paraneoplastic anti– <i>N</i> ‐methyl‐ <scp>D</scp> ‐aspartate receptor encephalitis associated with ovarian teratoma
|Annals of Neurology|2007|2.5k
Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis
|The Lancet Neurology|2010|2.4k